Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts

INTRODUCTION: Effective predictive biomarkers for selection of patients benefiting from adjuvant platinum-based chemotherapy in non-small cell lung cancer (NSCLC) are needed. Based on a previously validated methodology, molecular profiles of predicted sensitivity in two patient cohorts are presented...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Buhl, Ida Kappel, Santoni-Rugiu, Eric, Ravn, Jesper, Hansen, Anker, Christensen, Ib Jarle, Jensen, Thomas, Pratt, Bruce, Askaa, Jon, Jensen, Peter Buhl, Knudsen, Steen, Sørensen, Jens Benn
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5864030/
https://ncbi.nlm.nih.gov/pubmed/29566065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194609
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares